News - Page 37 - Psychedelic Alpha

Part 2 of our Year in Review video series is out now.

Read more about the article PharmaTher Submits Priority Original Abbreviated New Drug Application for KETARX™ (Ketamine) to the FDA

PharmaTher Submits Priority Original Abbreviated New Drug Application for KETARX™ (Ketamine) to the FDA

Post published:September 6, 2023
Post category:Press Release

Read more about the article COMPASS Pathways announces publication of first study evaluating potential of AI model to predict outcomes of COMP360 psilocybin treatment in treatment-resistant depression

COMPASS Pathways announces publication of first study evaluating potential of AI model to predict outcomes of COMP360 psilocybin treatment in treatment-resistant depression

Post published:September 6, 2023
Post category:Press Release

Read more about the article BetterLife Highlights BETR-001 Article in Technology Networks Drug Discovery and Announces Closing of a Private Placement

BetterLife Highlights BETR-001 Article in Technology Networks Drug Discovery and Announces Closing of a Private Placement

Post published:September 5, 2023
Post category:Press Release

Read more about the article Optimi Health Announces Second Tranche of CAD $1,000,000 Secured for Debt Financing

Optimi Health Announces Second Tranche of CAD $1,000,000 Secured for Debt Financing

Post published:September 5, 2023
Post category:Press Release

Read more about the article California Psychedelic Decriminalisation Bill Clears Appropriations Committee with Amendments

California Psychedelic Decriminalisation Bill Clears Appropriations Committee with Amendments

Post published:September 1, 2023
Post category:News

Read more about the article Natural Medicine Advisory Bulletin #3: August 2023

Natural Medicine Advisory Bulletin #3: August 2023

Post published:September 1, 2023
Post category:Colorado Natural Medicine Advisory Bulletin

Read more about the article Psychedelic Bulletin #144: Otsuka to Buy Mindset; Responses to FDA Draft Guidance; Cybin to Acquire Small Pharma; Usona Publishes Phase 2 Study

Psychedelic Bulletin #144: Otsuka to Buy Mindset; Responses to FDA Draft Guidance; Cybin to Acquire Small Pharma; Usona Publishes Phase 2 Study

Post published:August 31, 2023
Post category:Psychedelic Bulletin

Read more about the article FILAMENT HEALTH ENTERS LICENSING AGREEMENT WITH RESET PHARMA

FILAMENT HEALTH ENTERS LICENSING AGREEMENT WITH RESET PHARMA

Post published:August 31, 2023
Post category:Press Release

Read more about the article BREAKING: Big Pharma Company Otsuka to Acquire Mindset Pharma for CAD $80m

BREAKING: Big Pharma Company Otsuka to Acquire Mindset Pharma for CAD $80m

Post published:August 31, 2023
Post category:News

Read more about the article COMPASS Pathways to participate in upcoming September investor conferences

COMPASS Pathways to participate in upcoming September investor conferences

Post published:August 29, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.